08.07.2011 • News

Slovenia's Krka Jan-June Sales Up 6% Year-On-Year

Slovenia's top pharmaceutical company Krka said on Thursday group sales rose 6% in the first half of 2011 compared with the same period last year to reach €528.8 million ($756.4 million).

In a statement after a shareholders' meeting, it said the biggest sales rise was recorded in Eastern Europe where sales jumped 12% to €134.6 million.
Krka also said it planned to list its shares on bourses outside Slovenia but gave no details.

The company also plans to continue buying its shares to up to 10% of total equity in the next three years to use them as currency for possible takeovers. At present Krka owns 5.2% of its shares.

 

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.